Thyroid Fna,bethesda system

20
THYROID FNA DR ZAHID MAHMOOD FCPS(HISTOPATHOLOGY) KING EDWARD MEDICAL UNIVERSITY LAHORE

Transcript of Thyroid Fna,bethesda system

Page 1: Thyroid Fna,bethesda system

THYROID FNA

DR ZAHID MAHMOODFCPS(HISTOPATHOLOGY)

KING EDWARD MEDICAL UNIVERSITY LAHORE

Page 2: Thyroid Fna,bethesda system

Thyroid FNA Procedure

• US guidance

• 25 gauge needle

• 3-4 passes

FNA Thyroid

Page 3: Thyroid Fna,bethesda system

Fine Needle Non Aspiration (FNNA) biopsy showing needle, position & direction for biopsy.

Immediately after FNA, firm pressure is applied to biopsy sites

Page 4: Thyroid Fna,bethesda system

Technique and Equipment (Contd…)

Biopsy Procedure without aspiration

Page 5: Thyroid Fna,bethesda system

Difference between core and FNA biopsy

Page 6: Thyroid Fna,bethesda system

Needle is removed from syringe Air is aspirated into the syringe

Aspirated material is expelled onto the slides & smears are prepared

Page 7: Thyroid Fna,bethesda system

Technique and Equipment (Contd…)

Material in the hub of needle

Page 8: Thyroid Fna,bethesda system

Thyroid FNA Preparations

• Direct smears

- Air-dried, Diff Quik stained

- Ethanol fixed, Pap stained

• Cytospins • Cell block

• Liquid-based preparation

FNA Thyroid

DQ

PAP

CB

Core Biopsy

Page 9: Thyroid Fna,bethesda system

Thyroid FNA The Cell Pattern Approach

• CELLS– Arrangement– Nuclear features– Cytoplasmic features

• COLLOID

• BACKGROUND FEATURES

Page 10: Thyroid Fna,bethesda system

Clues to Diagnosis!

• More colloid ….more likely benign• More cells …. more likely neoplastic

Page 11: Thyroid Fna,bethesda system

The Bethesda System for Reporting Thyroid Cytopathology: 6 Diagnostic Categories

• I. NONDIAGNOSTIC or UNSATISFACTORY•• II. BENIGN

• III. ATYPIA OF UNDETERMINED SIGNIFICANCE or FOLLICULAR LESION OF UNDETERMINED SIGNIFICANCE

• IV. FOLLICULAR NEOPLASM or SUSPICIOUS FOR A FOLLICULAR NEOPLASM

• - specify if Hürthle cell (oncocytic) type

• V. SUSPICIOUS FOR MALIGNANCY

• VI. MALIGNANT•

Page 12: Thyroid Fna,bethesda system

TBRTC: Relationship to Clinical Algorithms

Category Cancer Risk Management

Nondiagnostic or Unsatisfactory

1-4% Repeat FNA with U/S

Benign <1-3 % Follow-up clinically

AUS, FLUS ~5-15 % Repeat FNA

Follicular Neoplasm, orSuspicious for a Follicular Neoplasm*

20-30 % Lobectomy

Suspicious for Malignancy(usually papillary CA)

60-75 % Lobectomy or total thyroidectomy

Malignant 97-99 % Total thyroidectomy

* Specify if Hürthle cell type

Page 13: Thyroid Fna,bethesda system

Thyroid FNA: made Easy

• Granulomatous Thyroiditis Giant cells munching on colloid• Hashimoto’s Thyroiditis Lymphocytes and oncocytes• Papillary carcinoma Papillae, nuclei and cytoplasm• Medullary carcinoma Carcinoid and amyloid • Anaplastic carcinoma Ugly giant and spindle cells• Follicular lesions? Colloid vs. follicular cells

Page 14: Thyroid Fna,bethesda system
Page 15: Thyroid Fna,bethesda system

Follicular Neoplasm

CYTOMORPHOLOGY

• Marked cellularity• Discohesion, single cells • Predominantly microfollicles

and/or trabeculae• Uniformly enlarged cells• Crowding • Scant colloid • Marked nuclear atypia, mitosis

and necrosis is uncommon

Page 16: Thyroid Fna,bethesda system

Papillary carcinoma

Follicular variant

Page 17: Thyroid Fna,bethesda system

VI: Malignant Papillary thyroid carcinoma

• Papillae- not very common

• Sheets: flat or syncytial

• Sheets/ clusters with well defined borders

• Clusters: 3-D

Page 18: Thyroid Fna,bethesda system

VI: Malignant Medullary thyroid carcinoma

Plasmacytoid cells Spindle cells

Page 19: Thyroid Fna,bethesda system

VI: Malignant Anaplastic carcinoma

Page 20: Thyroid Fna,bethesda system

FNA Breast lesions (reporting Categories)

C-1 Inadequate C-2 Benign

C-5 Malignant

C-3 Atypia (probably benign) C-4 Suspicious for malignancy